ROIV

Roivant Sciences Ltd (ROIV)

US
$ 00%

Price Chart

Key Statistics

Market Cap
$ 9.68B
P/E Ratio
0.00
Revenue (TTM)
$ 23.23M
Volume
0
52W High
$ 16.05
52W Low
$ 8.73
Dividend Yield
0.00%
Beta
1.15

Technicals

50-Day MA
11.9702
200-Day MA
11.2621
52 Week High
16.05
52 Week Low
8.73

About ROIV

Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.

Employees
750
Headquarters
London, United Kingdom
CEO
Mr. Matthew Gline

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg